Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Operating Expenses | 6,640 | 1,606 | 714 | 0 | 0 |
| Operating Income | -6,640 | -1,606 | -714 | N/A | N/A |
| Other Income | 1,178 | 615 | 0 | 0 | 0 |
| Pre-tax Income | -5,462 | -991 | -714 | 0 | 0 |
| Net Income Continuous | -5,462 | -991 | -714 | N/A | N/A |
| Net Income | $-5,462 | $-991 | $-714 | $N/A | $N/A |
| EPS Basic Total Ops | -0.87 | -3.51 | -2.57 | N/A | N/A |
| EPS Basic Continuous Ops | -0.87 | -3.50 | -2.57 | N/A | N/A |
| EPS Diluted Total Ops | -0.87 | -3.51 | -2.57 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.87 | -3.50 | -2.57 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.87 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-6,640 | $-1,601 | $-714 | $N/A | $N/A |